Guardant Health, Inc. Common Stock (GH) is a publicly traded Healthcare sector company. As of August 24, 2026, GH trades at $171.00 with a market cap of $22.91B and a P/E ratio of -51.51. GH moved +1.72% today. Year to date, GH is +67.11%; over the trailing twelve months it is +178.54%. Its 52-week range spans $30.15 to $176.58. Analyst consensus is strong buy with an average price target of $191.56. Rallies surfaces GH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks GH insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $171.00 |
| Market Cap | $22.91B |
| P/E Ratio | -51.51 |
| EPS | $-3.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $176.58 |
| 52-Week Low | $30.15 |
| Volume | 1.66M |
| Avg Volume | 0 |
| Revenue (TTM) | $982.02M |
| Net Income | $-416.28M |
| Gross Margin | 64.46% |
21 analysts cover GH: 0 strong buy, 21 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $191.56.